Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$104M |
 |
Mind Medicine (MindMed)MNMD |
-$45M |
 |
ModernaMRNA |
-$334B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Campbell Paul | Nov 11, 2024 | Sell | 26,925 | $12.876 | $350,000 |
| Malik Rajiv | Sep 12, 2024 | Sell | 139,681 | $11.6563 | $1.6M |
| Malik Rajiv | Sep 12, 2024 | Sell | 60,319 | $11.7136 | $710,000 |
| Malik Rajiv | Aug 30, 2024 | Sell | 50,000 | $12 | $600,000 |
| Malik Rajiv | Aug 23, 2024 | Sell | 100,000 | $11.751 | $1.2M |
| Malik Rajiv | Jun 14, 2024 | Sell | 264,300 | $10.1789 | $2.7M |
| Malik Rajiv | Jun 13, 2024 | Sell | 85,660 | $10.5153 | $900,000 |
| Roman Brian | May 28, 2024 | Sell | 89,419 | $10.3829 | $930,000 |
| Mauro Anthony | Mar 13, 2024 | Sell | 250,000 | $12.0948 | $3M |
| Campbell Paul | Mar 5, 2024 | Sell | 24,353 | $12.33 | $300,000 |
| Lyons Dillon JoEllen | Mar 5, 2024 | Sell | 20,000 | $12.36 | $250,000 |
| Ni Xiangyang (Sean) | Mar 4, 2024 | Sell | 17,755 | $12.5394 | $220,000 |
| Ni Xiangyang (Sean) | Mar 4, 2024 | Sell | 3,777 | $12.3582 | $47,000 |
| Cuneo Andrew | Feb 23, 2024 | Sell | 4,000 | $13.5 | $54,000 |
| Cuneo Andrew | Feb 15, 2024 | Sell | 4,000 | $12.5 | $50,000 |
| Cuneo Andrew | Jan 4, 2024 | Sell | 4,000 | $11.5 | $46,000 |
| Cuneo Andrew | Dec 14, 2023 | Sell | 4,000 | $10.5 | $42,000 |
| Ni Xiangyang (Sean) | Nov 24, 2023 | Sell | 14,937 | $9.3688 | $140,000 |
| KORMAN HARRY | Oct 26, 2023 | Buy | 19 | $9.007 | $170 |
| Ni Xiangyang (Sean) | Mar 6, 2023 | Sell | 3,148 | $11.0835 | $35,000 |
| Ni Xiangyang (Sean) | Mar 3, 2023 | Sell | 3,093 | $11.1798 | $35,000 |
| Ni Xiangyang (Sean) | Feb 28, 2023 | Sell | 5,250 | $11.2178 | $59,000 |
| Ni Xiangyang (Sean) | Nov 25, 2022 | Sell | 12,800 | $10.9547 | $140,000 |
What's the latest insider transaction for Viatris?
The most recent insider transaction for Viatris was conducted by Campbell Paul, who sold 26,925 shares on November 11, 2024 at a price of $12.88 per share.
Which insider bought the most VTRS stock over the last two years?
KORMAN HARRY has bought the most VTRS stock in the last 2 years, with a total value of $170.
Which insider has sold the most VTRS stock over the last two years?
Malik Rajiv has sold the most VTRS stock in the last 2 years, with a total value of $7.7M.
What is the total value of insider transactions for Viatris (VTRS) in the last 2 years?
The total value of insider transactions for Viatris in the last 2 years is negative, amounting to -$13M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Viatris' market confidence?
Over the last 2 years, insider transactions for Viatris have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
